When it comes to treating epilepsy, each patient needs a custom tailored regimen because the difference between a therapeutic dose and a toxic one is very small. A recent Medgadget article discussed a new breath test that can quickly determine the optimal drug treatment approach for each patient. The test was developed by researchers at Switzerland’s University of Basel, and it helps outline metabolic hallmarks to help clinicians determine the efficacy of a medication.
New Breath Test Determines Epilepsy Drug Regimen
Researchers in Switzerland have developed a breathalyzer test for anti-seizure medications.
Aug 17, 2021
INTRODUCING! The Latest Trends for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
Read More